Absence of significant adverse effects from low-dose subcutaneous epinephrine in dermatologic procedures.
Berbaum
M W
MW
Bredle
D L
DL
Futamara
W
W
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000772:Anesthesia, Local; D000779:Anesthetics, Local / Q000008:administration & dosage*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D062109:Dermatologic Surgical Procedures; D004837:Epinephrine / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007279:Injections, Subcutaneous; D011433:Propranolol / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000008:administration & dosage* / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D000779:Anesthetics, Local; D000959:Antihypertensive Agents; D014662:Vasoconstrictor Agents; D011433:Propranolol; D004837:Epinephrine